Citigroup Inc. Takes $241,000 Position in Augmedix, Inc. (NASDAQ:AUGX)

Citigroup Inc. bought a new stake in shares of Augmedix, Inc. (NASDAQ:AUGX) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 46,817 shares of the company’s stock, valued at approximately $241,000. Citigroup Inc. owned 0.11% of Augmedix as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Acadian Asset Management LLC purchased a new position in shares of Augmedix during the third quarter valued at approximately $48,000. Worth Venture Partners LLC purchased a new stake in Augmedix in the third quarter worth $83,000. Barclays PLC purchased a new stake in Augmedix in the third quarter worth $115,000. Tucker Asset Management LLC purchased a new stake in Augmedix in the second quarter worth $172,000. Finally, Tower Research Capital LLC TRC purchased a new stake in Augmedix in the third quarter worth $190,000. 87.11% of the stock is owned by hedge funds and other institutional investors.

Augmedix Trading Up 3.2 %

Augmedix stock opened at $4.04 on Thursday. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 17.18. The business’s fifty day simple moving average is $4.29 and its two-hundred day simple moving average is $4.91. Augmedix, Inc. has a 12 month low of $1.50 and a 12 month high of $6.25. The company has a market capitalization of $167.09 million, a price-to-earnings ratio of -8.98 and a beta of -0.14.

Analyst Ratings Changes

AUGX has been the topic of several recent research reports. Maxim Group reduced their price target on Augmedix from $6.50 to $5.00 and set a “buy” rating on the stock in a research note on Tuesday, March 19th. Evercore ISI reduced their price target on Augmedix from $6.50 to $4.50 and set an “in-line” rating on the stock in a research note on Tuesday, March 19th.

Augmedix Profile

Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Notes that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, a self-service mobile software application.